Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY: HIMS )

57.09 +10.74 (+23.19%)
Streaming Delayed Price Updated: 2:54 PM EST, Feb 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,483,461
Open 47.53
Bid (Size) 57.07 (2)
Ask (Size) 57.10 (2)
Prev. Close 46.34
Today's Range 47.14 - 57.92
52wk Range 9.141 - 46.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks Brush Off Global Trade Tensions, PPI Data
Stocks are firmly higher today, despite rising global trade tensions and another hotter-than-expected inflation reading. 
Via Talk Markets
Topics Economy Stocks / Equities World Trade
Exposures Interest Rates Tariff
Robinhood, Gilead Sciences, Crocs, Lincoln Electric, HubSpot, GE HealthCare And Other Big Stocks Moving Higher On Thursday
Via Benzinga

Performance

YTD
+126.53%
+126.53%
1 Month
+120.41%
+120.41%
3 Month
+106.83%
+106.83%
6 Month
+269.96%
+269.96%
1 Year
+502.16%
+502.16%

More News

Read More
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Hims & Hers Terrifies Big Pharma
Via The Motley Fool
Hims & Hers Health Unusual Options Activity For February 10
Via Benzinga
Hims & Hers Health Unusual Options Activity
Via Benzinga
Hims & Hers Health Unusual Options Activity For February 03
Via Benzinga
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
Via MarketBeat
Exposures Product Safety
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
Via The Motley Fool
Hims & Hers Takes Aim At Big Pharma In Controversial Super Bowl Ad — Retail Loves The Fight
Via Stocktwits
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst
Via Benzinga
Topics World Trade
Exposures Tariff
Unlocking the Growth Potential of NYSE:HIMS.
Via Chartmill
Is Hims & Hers Health Stock a Buy?
Via The Motley Fool
Super Bowl Commercials 2025: Complete List of Super Bowl LIX Ads And Companies Behind Them
Via Benzinga
IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad
Via Investor's Business Daily
EXCLUSIVE: Is Super Bowl $7M Ad Cost Worth It? 61% Say No, 18% Say They Looked Up Companies After Last Year's NFL Championship
Via Benzinga
Hims & Hers Health Unusual Options Activity
Via Benzinga
Super Bowl LIX Commercials: AI, Celebs, Muppets, Warren Buffett-Linked Brand Take The Spotlight
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars
Via Stocktwits
Hims & Hers Launches Health Collective and Community Member Council
From Hims & Hers
Via Business Wire
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
From Hims & Hers
Via Business Wire
Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
Via Benzinga
Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
Via MarketBeat
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Hims & Hers Health: A Stock to Trade or Own?
Via MarketBeat
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.